Cite Filings / SABS
Feed Companies Filings Check
Sign in

CIK 0001833214 · Non-accelerated filer<br>Smaller reporting company<br>Emerging growth company

SAB Biotherapeutics, Inc.

Sign in to watch
Ticker
SABS
Exchange
Nasdaq
Industry
Biological Products, (No Diagnostic Substances)
FY end
Dec 31
Incorporated
DE
Entity type
operating
EIN
853899721
Phone
305-845-2813
Business address
777 W 41ST ST, SUITE 401, MIAMI BEACH, FL, 33140
Former names
Big Cypress Acquisition Corp.
Filings Insiders Search text
All 433 Financials 108 Shareholder Meetings 11 Executive Compensation 98 Insider Trading 151 Beneficial Ownership Interest 47 Business Combinations 107 Public Offerings 62 Mutual Funds and ETFs 8 Others 37
›
Filed in
  1. No filings match these filters. Clear filters
  2. DEF 14A Proxy Proxy Statement 2026-04-30
  3. DEF 14A Proxy Proxy Statement 2025-08-29
  4. PRE 14A Proxy Proxy Statement (Preliminary) 2025-08-19
  5. DEF 14A Proxy Proxy Statement 2025-06-02
  6. DEF 14A Proxy Proxy Statement 2024-05-30
  7. DEF 14A Proxy Proxy Statement 2023-12-18
  8. PRE 14A Proxy Proxy Statement (Preliminary) 2023-12-08
  9. DEF 14A Proxy Proxy Statement 2023-10-30
  10. PRE 14A Proxy Proxy Statement (Preliminary) 2023-10-20
  11. DEF 14A Proxy Proxy Statement 2023-05-19
  12. DEF 14A Proxy Proxy Statement 2022-05-25

Page 1 of 1 · 11 filings

Connection lost

Reconnecting…

Cite Filings isn't responding

Reconnecting…